You are here

  • Home
  • Archive
  • Volume 88, Issue 5
  • Establishment of the first at-home natalizumab infusion service for the treatment of relapsing remitting multiple sclerosis (rmms)

Article metrics

Article menu
Download PDFPDF
POster Abstracts
Abstracts
79
Establishment of the first at-home natalizumab infusion service for the treatment of relapsing remitting multiple sclerosis (rmms)

 

Online download statistics by month:

Online download statistics by month: May 2017 to March 2024

AbstractFullPdf
May 2017113010
Jun 20173505
Jul 20172401
Aug 20173801
Sep 20172400
Oct 20173204
Nov 20171400
Dec 20172201
Jan 20182002
Feb 20186402
Mar 20183001
Apr 20185405
May 20183000
Jun 20184802
Jul 20187802
Aug 20187800
Sep 20184200
Oct 20185003
Nov 20185601
Dec 20182600
Jan 20193601
Feb 20194000
Mar 20194001
Apr 20196403
May 20191801
Jun 20193201
Jul 20196001
Aug 20194400
Sep 20195403
Oct 20197400
Nov 20193402
Dec 20195001
Jan 20205602
Feb 20208008
Mar 202010602
Apr 202012207
May 20208206
Jun 202010003
Jul 20204001
Aug 20203000
Sep 20205200
Oct 20207001
Nov 20208300
Dec 20204201
Jan 20217201
Feb 20215401
Mar 20217403
Apr 20219801
May 20213901
Jun 2021002
Aug 2021001
Sep 2021001
Oct 20212800
Nov 20212000
Dec 20213200
Jan 20226000
Feb 20222700
Mar 20225002
Apr 20225100
May 20226400
Jun 20227004
Jul 20222100
Aug 20227902
Sep 20223400
Oct 20227901
Nov 20221700
Dec 20221600
Jan 20232700
Feb 20237500
Mar 20233400
Apr 20233201
May 20231800
Jun 2023700
Jul 2023400
Aug 20231000
Sep 20232300
Oct 20231300
Nov 20232000
Dec 2023800
Jan 20241300
Mar 2024400
Total35600106